19-7639098-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BS1_Supporting
The NM_006949.4(STXBP2):c.167C>T(p.Thr56Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006949.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP2 | ENST00000221283.10 | c.167C>T | p.Thr56Ile | missense_variant, splice_region_variant | 3/19 | 1 | NM_006949.4 | ENSP00000221283.4 | ||
ENSG00000268400 | ENST00000698368.1 | n.*270C>T | splice_region_variant, non_coding_transcript_exon_variant | 5/20 | ENSP00000513686.1 | |||||
ENSG00000268400 | ENST00000698368.1 | n.*270C>T | 3_prime_UTR_variant | 5/20 | ENSP00000513686.1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250696Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135544
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461844Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727216
GnomAD4 genome AF: 0.000217 AC: 33AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74374
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.167C>T (p.T56I) alteration is located in exon 3 (coding exon 3) of the STXBP2 gene. This alteration results from a C to T substitution at nucleotide position 167, causing the threonine (T) at amino acid position 56 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Familial hemophagocytic lymphohistiocytosis 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 06, 2022 | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 56 of the STXBP2 protein (p.Thr56Ile). This variant is present in population databases (rs138007892, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with STXBP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 538147). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at